Assessment of autonomic dysfunction in Parkinson patients by electrocardiogram

Dusunen Adam - The Journal of Psychiatry and Neurological Sciences

Volumn 25, Issue 2, 2012, Pages 147-150

  Türk, Arzu Şanli ^a   Köksal, Ayhan ^a   Altiokka, Özlem ^a   Karademir, Fazilet ^a   Dirican, Ayten Ceyhan ^a   Altunkaynak, Yavuz ^a   Yazar, Tamer ^b   Baybaş, Sevim ^a  

^a Bakirkoy Prof Dr Mazhar Osman Research and Training Hospital for Psychiatry   (Turkey)

^b BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Autonomic dysfunction; ECG; Parkinson; QT interval

Indexed keywords

EID: 84867975366     PISSN: 10188681     EISSN: 13095749     Source Type: Journal    
DOI: 10.5350/DAJPN2012250207     Document Type: Article

References (14)

1. Iodice V, Low DA, Vichayanrat E, Mathias CJ. Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences. J Neurol Sci 2011; 310:133-138.
2. Mehndiratta M, Garg RK, Pandey S. Nonmotor symptom complex of Parkinson's disease: an under-recognized entity. J Assoc Physicians India 2011; 59:302-308.
3. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991; 84:1516-1523.
4. Choy AM, Lang CC, Roden DM, Robertson D, Wcood AJ, Robertson RM, Biaggioni I. Abnormalities of the QT interval in primary disorders of autonomic failure. Am Heart J 1998; 136:664-671.
5. Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol 1976; 37:1035-1040.
6. Ishizaki F, Harada T, Yoshinaga H, Nakayama T, Yamamura Y, Nakamura S. Prolonged QTc intervals in Parkinson's diseaserelation to sudden death and autonomic dysfuntion. No To Shinkei 1996; 48:443-448.
7. Lo SS, Mathias CJ, Sutton MS. Qt interval and dispersion in primary autonomic failure. Heart 1996; 75:498-501.
8. Oka H, Mochio S, Sato H, Katayama K. Prolongation of QTc interval in patients with Parkinson's disease. Eur Neurol 1997; 37:186-189.
9. Deguchi K, Sasaki I, Tsukaguchi M, Kamoda M, Touge T, Takeuchi H, Kuriyama S. Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Sci 2002; 199:31-37.
10. Komai N. Surgical treatment of Parkinson's disease. Nihon Rinsho 1993; 51:2940-2946.
11. Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihata M. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999; 52:1269-1271.
12. Hirsch EC. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann Neurol 1992; 32:88-93.
13. Hirsch EC. Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur Neurol 1993; 33:52-59.
14. Eisenhofer G, Esler MD, Meredith IT, Dart A, Cannon RO, Quyyumi AA, Lambert G, Chin J, Jennings GL, Goldstein GL. Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine. Circulation 1992; 85:1775-1785.